1. Home
  2. COSM vs UBX Comparison

COSM vs UBX Comparison

Compare COSM & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COSM
  • UBX
  • Stock Information
  • Founded
  • COSM 2009
  • UBX 2009
  • Country
  • COSM United States
  • UBX United States
  • Employees
  • COSM N/A
  • UBX N/A
  • Industry
  • COSM Other Pharmaceuticals
  • UBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • COSM Health Care
  • UBX Health Care
  • Exchange
  • COSM Nasdaq
  • UBX Nasdaq
  • Market Cap
  • COSM 12.9M
  • UBX 13.9M
  • IPO Year
  • COSM 2013
  • UBX 2018
  • Fundamental
  • Price
  • COSM $0.43
  • UBX $0.78
  • Analyst Decision
  • COSM
  • UBX Strong Buy
  • Analyst Count
  • COSM 0
  • UBX 3
  • Target Price
  • COSM N/A
  • UBX $4.67
  • AVG Volume (30 Days)
  • COSM 190.3K
  • UBX 521.0K
  • Earning Date
  • COSM 08-18-2025
  • UBX 08-05-2025
  • Dividend Yield
  • COSM N/A
  • UBX N/A
  • EPS Growth
  • COSM N/A
  • UBX N/A
  • EPS
  • COSM N/A
  • UBX N/A
  • Revenue
  • COSM $53,554,457.00
  • UBX N/A
  • Revenue This Year
  • COSM $28.14
  • UBX N/A
  • Revenue Next Year
  • COSM N/A
  • UBX N/A
  • P/E Ratio
  • COSM N/A
  • UBX N/A
  • Revenue Growth
  • COSM N/A
  • UBX N/A
  • 52 Week Low
  • COSM $0.28
  • UBX $0.66
  • 52 Week High
  • COSM $1.58
  • UBX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • COSM 45.07
  • UBX 48.12
  • Support Level
  • COSM $0.42
  • UBX $0.67
  • Resistance Level
  • COSM $0.47
  • UBX $0.83
  • Average True Range (ATR)
  • COSM 0.03
  • UBX 0.09
  • MACD
  • COSM -0.00
  • UBX 0.01
  • Stochastic Oscillator
  • COSM 21.56
  • UBX 24.67

About COSM Cosmos Health Inc.

Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Share on Social Networks: